Humana Inc. ($HUM) Stock Forecast: Down 5.3% Today

What is Humana Inc.?

Humana Inc. (HUM) is a leading health insurance company in the United States, offering a wide range of healthcare products and services to its customers. The company's stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol HUM.

Why is Humana Inc. going down?

HUM stock is down 5.3% on Sep 19, 2025 14:40

• The bearish movement in Humana's stock today could be attributed to an investigation initiated by the former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., into the officers and directors of the company. This news might have raised concerns among investors about potential legal issues or regulatory challenges that could impact Humana's operations and financial performance.
• The uncertainty surrounding the investigation could have led to a lack of confidence in the company's leadership and governance practices, prompting investors to sell off their positions in Humana's stock.
• As investors typically react negatively to legal investigations and regulatory scrutiny, the bearish trend in Humana's stock today reflects the market's cautious sentiment towards the company's current situation and the potential implications of the ongoing probe.

HUM Price Chart

HUM Technical Analysis

HUM News

HUMANA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humana Inc. - HUM - Humana ( NYSE:HUM )

NEW ORLEANS, Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ( "KSF" ) , announces that KSF has commenced an investigation into Humana Inc. ( "Humana" or "the Company" ) HUM.

https://www.benzinga.com/pressreleases/25/09/g47750941/humana-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick-foti-llc-investigat

Trending Today

Binance Coin ($BNB) Crypto Forecast: Up 5.0% Today

Humana Inc. Price History

17.03.2025 - HUM Stock was down 7.1%

• Despite optimistic activities in the options trading market, Humana (HUM) witnessed a notable bearish movement, suggesting a divergence between options trading sentiment and actual stock performance.
• This discrepancy in market behavior could stem from broader market conditions or specific company-related events that were not reflected in the options trading data.
• It is possible that investors reacted to negative developments or news surrounding Humana, leading to the downward trajectory in the stock price despite the positive sentiment in options positions.

17.03.2025 - HUM Stock was down 7.3%

• Humana's stock experienced a bearish movement today, likely influenced by the negative earnings report from UnitedHealth, a major competitor in the health insurance industry.
• The disappointing earnings results from UnitedHealth may have raised concerns among investors about the overall health insurance sector, leading to a sell-off in stocks like Humana.
• This market reaction highlights the interconnectedness of companies within the same industry, where one company's performance can impact the sentiment and stock prices of its competitors.
• Investors will be closely monitoring future earnings reports and industry developments to assess the potential impact on Humana's stock performance in the coming days.

12.01.2025 - HUM Stock was up 5.5%

• Despite facing a wider year-over-year loss in Q4 due to a decline in membership, Humana's stock showed strong bullish movement recently.
• The positive market response can likely be linked to Humana's impressive 13% revenue growth in Q4, exceeding expectations and demonstrating the company's strength in a challenging business landscape.
• Furthermore, Humana's stock has outperformed the market by 2.35% annually over the past two decades, potentially boosting investor confidence and driving the current bullish trend.
• The ongoing lawsuit concerning specific investors in Humana shares seems to have had minimal impact on the stock's performance, with market attention mainly focusing on the company's financial results and future growth prospects.

13.04.2025 - HUM Stock was down 6.2%

• Indications of optimistic trading positions from wealthy investors may have boosted confidence in Humana's future.
• Legal inquiries by law firms potentially regarding claims against Humana could have prompted worries about legal risks and compliance challenges, resulting in a decline in the stock value.
• The interplay between positive options activity and legal scrutiny probably generated market unpredictability and unease, influencing the downward trend in Humana's stock value.

02.08.2025 - HUM Stock was up 3.0%

• Humana's strong bullish movement today can be attributed to the company's expansion of musculoskeletal care access through new value-based partnerships. This move not only enhances the company's service offerings but also demonstrates its commitment to improving healthcare outcomes for its members.
• The positive investor sentiment towards Humana may also be fueled by the company's solid financial performance, as indicated by its 19.2% increase since the last earnings report. This growth trajectory suggests that Humana is effectively executing its strategic initiatives and delivering value to its shareholders.
• In contrast, the struggles faced by Centene may have further boosted investor confidence in Humana. The comparison with Centene, which has seen a significant decline in its share price, likely underscored Humana's relative strength and stability in the healthcare sector.

19.08.2025 - HUM Stock was down 5.3%

• The bearish movement in Humana's stock today could be attributed to an investigation initiated by the former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., into the officers and directors of the company. This news might have raised concerns among investors about potential legal issues or regulatory challenges that could impact Humana's operations and financial performance.
• The uncertainty surrounding the investigation could have led to a lack of confidence in the company's leadership and governance practices, prompting investors to sell off their positions in Humana's stock.
• As investors typically react negatively to legal investigations and regulatory scrutiny, the bearish trend in Humana's stock today reflects the market's cautious sentiment towards the company's current situation and the potential implications of the ongoing probe.

17.05.2025 - HUM Stock was up 5.0%

• UnitedHealth's strong bullish movement today can be attributed to the company's medical membership surpassing 50 million, indicating a growing customer base and revenue potential.
• Concerns about high Medicare costs may have initially dampened investor sentiment, but the overall positive trend in the healthcare sector likely overshadowed these worries.
• The company's ability to maintain this momentum will depend on its strategies to manage and control costs, while continuing to attract and retain members in a competitive market.
• Investors are likely optimistic about UnitedHealth's growth prospects, despite the challenges posed by healthcare costs, driving the stock's bullish movement today.

08.03.2025 - HUM Stock was up 13.8%

• Humana (HUM) experienced a bullish movement today, potentially influenced by positive market sentiment and overall optimism in the healthcare sector.
• The strong bullish movement in Centene (CNC) might have had a spillover effect on other health insurance companies like Humana, contributing to its upward momentum.
• The positive trend in earnings estimate revisions for Centene might have also boosted investor confidence in the healthcare sector as a whole, including companies like Humana.
• Overall, the bullish movement in Humana (HUM) today could be attributed to a combination of sector-wide optimism, positive market sentiment, and potential spillover effects from other strong performers in the healthcare industry.

06.07.2025 - HUM Stock was up 5.4%

• There is an ongoing investigation on behalf of long-term stockholders regarding Humana Inc., which could indicate potential legal issues or concerns within the company.
• Investors who have faced losses with Humana are being advised to consult a litigation attorney, hinting at possible ongoing challenges or uncertainties affecting the stock.
• The positive movement in Humana's stock today could be linked to favorable earnings reports, new business ventures, or market speculation on future growth prospects.
• Despite the investigation and potential losses, investors seem optimistic about Humana's resilience in navigating legal issues and providing value, leading to increased buying activity and a higher stock price.

17.06.2025 - HUM Stock was down 0.3%

• Analysis indicates that Humana's shares are oversold and close to a support level, suggesting a potential turnaround with a upward movement soon.
• Although the stock consolidated on Wednesday, there is hope for a shift from a bearish trend to a bullish rally.
• The downward movement might be due to general market sentiment or industry-specific updates affecting Humana's stock value.
• Traders are advised to monitor any further developments closely to evaluate the possibility of a positive reversal in Humana's stock.

30.06.2025 - HUM Stock was up 5.4%

• Humana (HUM) reported Q2 earnings that slightly lagged estimates, but revenue exceeded expectations, showing overall positive performance.
• The strength in insurance premiums and Medicare helped offset rising costs and membership declines, indicating resilience in the company's core business.
• Analysts expect Humana to beat earnings estimates, suggesting positive sentiment and potential for the stock to move higher in the near future.
• The combination of positive revenue surprises and expectations of beating earnings estimates likely contributed to the strong bullish movement in Humana's stock today.

30.06.2025 - HUM Stock was up 7.9%

• Humana exceeded Q2 adjusted EPS expectations, showcasing resilience and strong financial performance.
• The company's upward revision of its 2025 revenue forecast to at least $128 billion indicates robust growth prospects and strategic planning.
• Despite some concerns about earnings lagging estimates and rising costs, the overall market sentiment towards Humana seems positive, driven by its solid performance and future growth potential.